Mebazaa, A.
Tolppanen, H.
Mueller, C.
Lassus, J.
DiSomma, S.
Baksyte, G.
Cecconi, M.
Choi, D. J.
Cohen Solal, A.
Christ, M.
Masip, J.
Arrigo, M.
Nouira, S.
Ojji, D.
Peacock, F.
Richards, M.
Sato, N.
Sliwa, K.
Spinar, J.
Thiele, H.
Yilmaz, M. B.
Januzzi, J.
Article History
Received: 23 April 2015
Accepted: 26 August 2015
First Online: 14 September 2015
Compliance with ethical standards
:
: A. Mebazaa received speaker’s honoraria from The Medicines Company, Novartis, Orion, Servier, Vifor Pharma, and fee as member of advisory board and/or Steering Committee from Cardiorentis, The Medicine Company, Adrenomed and Critical Diagnostics.J. Lassus has received consulting and speaker’s honoraria from Bayer, Boeringer Ingelheim, Novartis, Orion Pharma, Pfizer, ResMed, Roche Diagnostics, Servier and Vifor Pharma.W.F. Peacock received research grants from Abbott, Alere, Banyan, Cardiorentis, Janssen, Portola, Pfizer, Roche, The Medicine’s Company and consultant fees from Alere, Cardiorentis, Janssen, Alere, Cardiorentis, and Janssen. W.F. Peacock has Ownerships in Comprehensive Research Associates LLC, Emergencies in Medicine LLC.M.B. Yilmaz received research fee from Novartis and Cardiorentis.A. Cohen Solal received speaker and consulting fees from Actelion, Ipsen, Sorin, Abbott, Novartis, Thermofisher, Alere, Pfizer, Vifor, Amgen, Servier, Bayer, Sanofi, and Boehringer Ingelheim.M. Christ has received grants for clinical studies and speaking honoraria by Novartis GmbH, Alere GmbH and Roche Diagnostics, Germany.J. Januzzi has received grants from Thermo-Fisher, Prevencio, Siemens, and Singulex; consulting fees from Novartis, Critical Diagnostics, Radiometer, diaDexus.CEC; and fees for data and safety monitoring board (DSMB): Novartis, Amgen, Boeringer-Ingelheim.Other co-authors have no conflict of interests.
Free to read: This content has been made available to all.